ID29262A - Komposisi farmasi - Google Patents

Komposisi farmasi

Info

Publication number
ID29262A
ID29262A IDW20002464A ID20002464A ID29262A ID 29262 A ID29262 A ID 29262A ID W20002464 A IDW20002464 A ID W20002464A ID 20002464 A ID20002464 A ID 20002464A ID 29262 A ID29262 A ID 29262A
Authority
ID
Indonesia
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
IDW20002464A
Other languages
English (en)
Inventor
Rinta Ibuki
Fumio Shimojo
Satoshi Ueda
Toshihiko Toyoda
Masayuki Yamanaka
Erika Yoshida
Hideo Seki
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of ID29262A publication Critical patent/ID29262A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDW20002464A 1998-04-27 1999-04-26 Komposisi farmasi ID29262A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11727198 1998-04-27

Publications (1)

Publication Number Publication Date
ID29262A true ID29262A (id) 2001-08-16

Family

ID=14707636

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002464A ID29262A (id) 1998-04-27 1999-04-26 Komposisi farmasi

Country Status (24)

Country Link
US (2) US6673808B1 (id)
EP (1) EP1074255B1 (id)
JP (1) JP3732525B2 (id)
KR (1) KR100406823B1 (id)
CN (1) CN1161117C (id)
AR (1) AR018330A1 (id)
AT (1) ATE363275T1 (id)
AU (1) AU749475B2 (id)
BR (1) BR9910336A (id)
CA (1) CA2326222C (id)
DE (1) DE69936195T2 (id)
ES (1) ES2284248T3 (id)
HK (1) HK1038884B (id)
HU (1) HUP0104452A3 (id)
ID (1) ID29262A (id)
IL (1) IL139210A (id)
NO (1) NO20005399L (id)
NZ (1) NZ507345A (id)
PL (1) PL343627A1 (id)
RU (1) RU2203058C2 (id)
TR (1) TR200003108T2 (id)
TW (1) TW565461B (id)
WO (1) WO1999055332A1 (id)
ZA (1) ZA200005378B (id)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
IL146162A0 (en) * 1999-04-30 2002-07-25 R Tech Ueno Ltd Macrolide compounds for the treatment of dry eye
SI2762140T1 (sl) * 2001-02-19 2017-07-31 Novartis Ag Zdravljenje trdnih možganskih tumorjev z derivatom rapamicina
GB0108498D0 (en) * 2001-04-04 2001-05-23 Novartis Ag Organic Compounds
AUPR529701A0 (en) * 2001-05-28 2001-06-21 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition
PE20030828A1 (es) * 2002-03-04 2003-11-04 Novartis Ag Composicion oftalmica que comprende ascomicina
GB0218996D0 (en) * 2002-08-14 2002-09-25 Novartis Ag Organic compounds
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
US7083802B2 (en) * 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
CA3031270A1 (en) 2004-03-03 2005-12-22 Revance Therapeutics, Inc. Compositions and methods for topical diagnostic and therapeutic transport
WO2006001251A1 (ja) * 2004-06-24 2006-01-05 Kowa Co., Ltd. アトルバスタチン外用剤組成物
EP1861112A4 (en) 2005-03-03 2009-07-22 Revance Therapeutics Inc COMPOSITIONS AND METHODS FOR TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULINUM TOXINS
CA2615990A1 (en) 2005-07-18 2007-01-25 Minu, L.L.C. Enhanced ocular neuroprotection/neurostimulation
FR2900052B1 (fr) * 2006-04-19 2011-02-18 Galderma Sa Composition comprenant au moins une phase aqueuse et au moins une phase grasse comprenant de l'ivermectine
CN101288643B (zh) * 2008-06-17 2012-11-14 杨喜鸿 含有他克莫司的凝胶剂组合物及其制备方法和药物应用
EP2345414B1 (en) * 2008-10-08 2014-06-25 Takata Seiyaku Co., Ltd. Tacrolimus preparation for external applications
GB0917816D0 (en) 2009-10-12 2009-11-25 Biotica Tech Ltd Novel compounds and methods for their production
GB0917817D0 (en) 2009-10-12 2009-11-25 Biotica Tech Ltd Novel compounds and methods for their production
JP2011102260A (ja) * 2009-11-11 2011-05-26 Takada Seiyaku Kk タクロリムス外用剤
JP5674786B2 (ja) * 2010-07-23 2015-02-25 マルホ株式会社 タクロリムスを含有する水中油型クリーム状組成物
WO2012011192A1 (ja) * 2010-07-23 2012-01-26 マルホ株式会社 タクロリムスを含有する水中油型クリーム状組成物
JP5652795B2 (ja) * 2011-01-31 2015-01-14 国立大学法人大阪大学 皮膚疾患を処置するための外用薬およびその製造方法
CA3165081A1 (en) * 2020-01-24 2021-07-29 Toru Yasuzawa External preparation containing rapamycin

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454113A (en) * 1982-09-21 1984-06-12 Scm Corporation Stabilization of oil and water emulsions using polyglycerol esters of fatty acids
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US4973468A (en) * 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
DK0474126T3 (id) * 1990-09-04 1997-04-07 Fujisawa Pharmaceutical Co
TW213418B (id) * 1991-05-02 1993-09-21 Kuko Seiyaku Kk
JPH06128148A (ja) * 1992-04-30 1994-05-10 Dotsuto:Kk 皮膚外用剤
JP2523428B2 (ja) * 1992-12-04 1996-08-07 エスエス製薬株式会社 消炎鎮痛ゲル製剤
JPH06345646A (ja) * 1993-06-08 1994-12-20 Fujisawa Pharmaceut Co Ltd ローション剤
ATE214593T1 (de) * 1994-10-26 2002-04-15 Novartis Erfind Verwalt Gmbh Verwendung eines ungesättigten fettalkohols
WO1997024112A1 (fr) * 1995-12-28 1997-07-10 Yoshitomi Pharmaceutical Industries, Ltd. Preparation a usage externe
CZ267796A3 (cs) 1996-09-12 1998-04-15 Galena A.S. Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů
TW450810B (en) * 1997-02-20 2001-08-21 Fujisawa Pharmaceutical Co Macrolides antibiotic pharmaceutical composition for preventing and treating skin diseases
JP4221762B2 (ja) * 1997-04-11 2009-02-12 アステラス製薬株式会社 医薬組成物

Also Published As

Publication number Publication date
CN1161117C (zh) 2004-08-11
AU3537299A (en) 1999-11-16
ZA200005378B (en) 2002-08-23
IL139210A0 (en) 2001-11-25
HUP0104452A2 (hu) 2002-03-28
HK1038884A1 (en) 2002-04-04
NO20005399D0 (no) 2000-10-26
DE69936195D1 (de) 2007-07-12
KR100406823B1 (ko) 2003-11-21
HK1038884B (zh) 2005-05-06
JP3732525B2 (ja) 2006-01-05
TW565461B (en) 2003-12-11
CN1307475A (zh) 2001-08-08
NZ507345A (en) 2002-12-20
HUP0104452A3 (en) 2004-05-28
RU2203058C2 (ru) 2003-04-27
DE69936195T2 (de) 2007-09-13
ATE363275T1 (de) 2007-06-15
EP1074255A1 (en) 2001-02-07
CA2326222C (en) 2008-09-23
IL139210A (en) 2005-11-20
US6586444B2 (en) 2003-07-01
US6673808B1 (en) 2004-01-06
AR018330A1 (es) 2001-11-14
ES2284248T3 (es) 2007-11-01
BR9910336A (pt) 2001-09-25
CA2326222A1 (en) 1999-11-04
US20020061907A1 (en) 2002-05-23
PL343627A1 (en) 2001-08-27
KR20010042589A (ko) 2001-05-25
EP1074255B1 (en) 2007-05-30
NO20005399L (no) 2000-10-26
WO1999055332A1 (fr) 1999-11-04
EP1074255A4 (en) 2002-02-13
AU749475B2 (en) 2002-06-27
TR200003108T2 (tr) 2001-02-21
WO1999055332A8 (fr) 2000-02-17

Similar Documents

Publication Publication Date Title
ID27415A (id) Komposisi farmaseutik
NO20005913D0 (no) Legemiddelsammensetning
EA199900373A3 (ru) Фармацевтические композиции
NO20015175L (no) Farmasöytisk sammensetning
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
ID29262A (id) Komposisi farmasi
FI991485A0 (fi) Uusi farmaseuttinen koostumus
ID29089A (id) Sediaan farmasi moksifloksasin
DK1466615T3 (da) Farmaceutisk præparat
DE69942892D1 (de) Gaserzeugende zusammensetzung
DE69928862D1 (de) Zusammensetzung
ID27201A (id) Komposisi farmasi
ID27150A (id) Sediaan levotiroksin bahan farmasi
ID29294A (id) Komposisi farmasi
ID30032A (id) Formulasi farmasi
ID25857A (id) Komposisi farmasi
FI4488U1 (fi) Farmaseuttinen koostumus
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
ID18698A (id) Komposisi farmasi
EE200100281A (et) Analgeetiline ravimkoostis
ID26215A (id) Komposisi farmasi
ITMI962628A0 (it) Composizione farmaceutica
DE69939964D1 (de) Gelförmige Zusammensetzung
ID23531A (id) Komposisi farmasi
FI981567A0 (fi) Farmaseuttiset koostumukset